Sulfur News and Research

RSS

In-mouth production of volatile sulfur compounds causes children to dislike Brassica vegetables

Many children, as well as adults, dislike Brassica vegetables, such as broccoli, cauliflower, cabbage and Brussels sprouts.

22 Sep 2021

Preventing Wine Adulteration

Gordon Burns is the technical director and co-founder of ETS Laboratories, which runs specialist wine analysis labs based in the Napa Valley in California. The North American wine industry has quite a different story to tell than honey that was discussed in another interview when it comes to authenticity issues.

From Bruker BioSpin - NMR, EPR and Imaging 22 Sep 2021

New study reveals chemical steps in an important cellular modification process

The chemical steps in an important cellular modification process that adds a chemical tag to some RNAs have been revealed in a new study. Interfering with this process in humans can lead to neuronal diseases, diabetes, and cancers.

16 Sep 2021

Portable, thumb-sized device quickly detects bad breath

No one wants bad breath -- not when visiting friends and family, at a job interview, and especially not on a first date.

21 Jul 2021

Nanomaterials' physiochemical properties influence their ability to penetrate the blood brain barrier

Nanomaterials found in consumer and health-care products can pass from the bloodstream to the brain side of a blood-brain barrier model with varying ease depending on their shape - creating potential neurological impacts that could be both positive and negative, a new study reveals.

5 Jul 2021

Vaccines grown in eggs can lead to an off-target antibody response

Over years of studying antibody responses against the flu in the Wilson lab at the University of Chicago, researchers kept coming up with a strange finding: antibodies that seemed to bind not only to the flu virus but to every virus the lab could throw at them.

2 Jul 2021

Study reports self-disinfecting polymer surfaces that can inactivate SARS-CoV-2

Surfaces with anionic block copolymers can inactivate different viruses within minutes by making the polymer-microbe interface very acidic. Such surfaces can continuously disinfect surfaces without the need for reapplication of disinfectant.

14 Jun 2021

Cysteine persulfide found to be a new culprit in antibacterial resistance

A joint research project based in Kumamoto University, Japan has developed a new, highly sensitive analytical method that can detect degraded β-lactam antibacterial agents used in the treatment of bacterial infections.

9 Jun 2021

Restoration can improve mining contamination, indicates study

Mining involves moving a lot of rock, so some mess is expected. However, mining operations can continue to affect ecosystems long after activity has ended. Heavy metals and corrosive substances leach into the environment, preventing wildlife and vegetation from returning to the area.

9 Jun 2021

NIH study identifies promising oral antiviral treatment for COVID-19

The experimental drug TEMPOL may be a promising oral antiviral treatment for COVID-19, suggests a study of cell cultures by researchers at the National Institutes of Health.

3 Jun 2021

Review: Sulfur-containing natural products isolated from marine organisms

Announcing a new publication for Marine Life Science & Technology journal. In this review article the authors Yang Hai, Mei‑Yan Wei, Chang‑Yun Wang, Yu‑Cheng Gu and Chang‑Lun Shao from Ocean University of China, Qingdao, China and Syngenta Jealott's Hill International Research Centre, Berkshire, UK consider the chemistry and biology of sulfur‑containing natural products from marine microorganisms.

31 May 2021

Novel natural compounds may help treat COVID-19, study suggests

A new study in the journal Chemistry Europe reports two natural compounds identified by virtual screening and computational modeling as having great promise for the development of drugs against SARS-CoV-2.

24 May 2021

Celastrol shows potential anti-SARS-CoV-2 activity

A new study published on the bioRxiv* preprint server focuses on the in-silico predictions to repurpose existing drug compounds, that may have the ability to reverse the SARS-CoV-2 gene expression induced in host cells.

23 Apr 2021

Researchers develop “Nano-Glue” with therapeutic potential against SARS-CoV-2

In a recent study, researchers target the electropositive receptor-binding domain (RBD) on the SARS-CoV-2 spike protein with the abundant β-sheet structure as a novel COVID-19 therapeutic drug design.

15 Apr 2021

New data reveals the effect of lockdowns on air pollution levels

One consequence of the coronavirus pandemic has been global restrictions on mobility. This, in turn, has had an effect on pollution levels in the atmosphere.

15 Apr 2021

Researchers uncover new metabolic capabilities of gut bacteria

An international team of scientists led by microbiologists Alexander Loy from the University of Vienna and David Schleheck from the University of Konstanz has uncovered new metabolic capabilities of gut bacteria.

9 Apr 2021

Hydrogels offer new hope for cancer treatment

Hydrogels are often used as drug delivery systems, but to be effective carriers for anti-cancer drugs, they need to be responsive to varied stimuli in the tumor microenvironment.

8 Apr 2021

Study may help develop effective biosensors for non-invasive diagnosis of prostate cancer

The efficacy of biosensors used in clinical tests depends critically on the surface of the device on which the biorecognition molecules are immobilized.

23 Mar 2021

The role of S-acylation in the enhancement of SARS-CoV-2 infectivity

A new study published on the bioRxiv server focuses on the role of S-acylation in the SARS-CoV-2 infection cycle. It has also characterized Spike acylation and has also identified other acylated viral proteins and host enzymes involved in the process of infection. Further, it has also revealed the importance of acylation in viral biogenesis and infection.

18 Mar 2021

New system may offer improved options for cancer treatment

Improved options for cancer treatment are on the way, thanks to a new system developed at Los Alamos National Laboratory for producing alpha-emitting medical radioisotopes intended to target and overpower diseased tissue while sparing the healthy tissue around it.

11 Mar 2021